This article is available to subscribers. Subscribe now. Already have an account? Sign in

Review ArticleMedical ProgressFree Preview

Oral Contraceptives and the Risk of Venous Thrombosis

List of authors.
  • Jan P. Vandenbroucke, M.D., Ph.D.,
  • Jan Rosing, Ph.D.,
  • Kitty W.M. Bloemenkamp, M.D., Ph.D.,
  • Saskia Middeldorp, M.D., Ph.D.,
  • Frans M. Helmerhorst, M.D., Ph.D.,
  • Bonno N. Bouma, Ph.D.,
  • and Frits R. Rosendaal, M.D., Ph.D.

In the early 1960s, shortly after the introduction of oral contraceptives, the first case reports appeared describing venous thrombosis and pulmonary emboli in women using this method of birth control. Later, myocardial infarction and stroke were also found to be associated with the use of oral contraceptives. These observations led to numerous epidemiologic and clinical studies of oral-contraceptive pills and thrombosis and subsequently to the development of new oral contraceptives with a lower estrogen content. These lower-estrogen contraceptives were considered safer: changes in hemostatic factors remained small, inconsistent in direction, and mostly within the normal range.14 Recent studies have . . .

Continue reading this article

Select an option below:

Create your account to get 2 free subscriber-only articles each month.

Get Free Access Now Subscribe For Full Access

Already have an account?

Sign In

Print subscriber?

Activate your online access.

Funding and Disclosures

We are indebted to the following persons for their previous collaboration and their extensive personal contributions to several of the studies described in this review: Dr. J. Curvers, Dr. G. Nicolaes, Dr. G. Tans, and Mrs. M.C.L.G.D. Thomassen of the Department of Biochemistry, Cardiovascular Research Institute, Maastricht; Professor H.R. Büller, Dr. J.C.M. Meijers, and Dr. M.H. Prins of the Department of Vascular Medicine, Academic Medical Center, Amsterdam; and Professor R.M. Bertina of the Thrombosis and Hemostasis Research Center, Leiden University Medical Center, Leiden — all in the Netherlands.

Author Affiliations

From the Department of Clinical Epidemiology (J.P.V., F.R.R.), the Department of Obstetrics, Gynecology, and Reproductive Medicine (K.W.M.B., F.M.H.), and the Thrombosis and Haemostasis Research Center (F.R.R.), Leiden University Medical Center, Leiden; the Department of Biochemistry, Cardiovascular Research Institute, Maastricht (J.R.); the Department of Vascular Medicine, Academic Medical Center, Amsterdam (S.M.); and the Thrombosis and Hemostasis Laboratory, Department of Hematology, University Hospital Utrecht, Utrecht (B.N.B.) — all in the Netherlands.

Address reprint requests to Dr. Vandenbroucke at the Department of Clinical Epidemiology, Leiden University Medical Center, P.O. Box 9600, 2300 RC Leiden, the Netherlands, or at .

Print Subscriber? Activate your online access.